Page 15 - Nyse Agl News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nyse agl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nyse Agl Today - Breaking & Trending Today
Agilon health (NYSE:AGL – Get Rating) had its target price upped by SVB Leerink from $25.00 to $33.00 in a research note issued to investors on Thursday, MarketBeat reports. SVB Leerink currently has an outperform rating on the stock. Other equities research analysts also recently issued research reports about the stock. Zacks Investment Research upgraded […] ....
Guggenheim began coverage on shares of agilon health (NYSE:AGL – Get Rating) in a research report released on Tuesday morning, Marketbeat reports. The firm issued a buy rating and a $32.00 price objective on the stock. AGL has been the topic of several other reports. Deutsche Bank Aktiengesellschaft decreased their price target on shares of […] ....
Agilon health (NYSE:AGL – Get Rating) is one of 29 publicly-traded companies in the “Miscellaneous health & allied services, not elsewhere classified” industry, but how does it compare to its peers? We will compare agilon health to similar companies based on the strength of its analyst recommendations, institutional ownership, profitability, risk, valuation, dividends and earnings. […] ....
Agilon health (NYSE:AGL – Get Rating) is one of 29 publicly-traded companies in the “Miscellaneous health & allied services, not elsewhere classified” industry, but how does it contrast to its rivals? We will compare agilon health to related companies based on the strength of its institutional ownership, dividends, earnings, analyst recommendations, profitability, risk and valuation. […] ....
Agilon health (NYSE:AGL – Get Rating) is one of 29 public companies in the “Miscellaneous health & allied services, not elsewhere classified” industry, but how does it contrast to its rivals? We will compare agilon health to related businesses based on the strength of its risk, valuation, institutional ownership, earnings, profitability, dividends and analyst recommendations. […] ....